Skip to content

A randomized controlled clinical study of two minimally invasive surgical treatments for open angle glaucoma

A randomized controlled clinical study of two minimally invasive surgical treatments for open angle glaucoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066650
Enrollment
Unknown
Registered
2022-12-13
Start date
2022-03-22
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glacoma

Interventions

A group:gonioscopy-assisted transluminal Trabeculotomy
B group:Partial trabeculotomy

Sponsors

Beijing Tongren Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients with POAG and JOAG diagnosis. 2) Patients without any anti glaucoma surgery. 3) The age is between 18-75 years old. 4) The patient who has used anti glaucoma drugs cannot continue to use intraocular pressure lowering drugs due to personal reasons, or hopes to reduce the dosage of intraocular pressure lowering drugs. 5) Patients who have used a variety of anti glaucoma drugs and whose intraocular pressure is still poorly controlled. 6) Understand and volunteer the corresponding surgical treatment, and can understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Glaucoma patients who have undergone anti glaucoma surgery. 2) Angle closure glaucoma and secondary open angle glaucoma (including but not limited to: neovascular secondary glaucoma, traumatic glaucoma, etc.). 3) Patients with scar in Scheme tube. 4) Patients with corneal opacity and inability to clearly view the structure of the atrial angle. 5) The patient's own condition is not suitable for anti glaucoma surgery under general anesthesia, for example: the anticoagulant cannot be stopped, and the retinal degeneration area or hole is not Treatment, etc. 6) Patients who can not cooperate with the measurement of intraocular pressure due to eye conditions, such as strabismus with large angle, corneal edema, corneal scar, etc. 7) Other diseases other than glaucoma that may affect the evaluation of intraocular pressure: intraocular or orbital tumors, iris neovascularization, etc. 8) Patients who cannot accept general anesthesia due to their own conditions or cannot tolerate general anesthesia surgery due to their general conditions. 9) Pregnant women. 10) Patients unable to sign the informed consent form due to various reasons.

Design outcomes

Primary

MeasureTime frame
Intraoperative and postoperative complications;Intraocular pressure;Use of intraocular pressure lowering drugs;Operation success rate;

Secondary

MeasureTime frame
visual field;Operation success rate;

Countries

China

Contacts

Public ContactNingliWang

Beijing Tongren Hospital Affiliated to Capital Medical University

wningli@vip.163.com13511026669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026